Skip to main content
    R

    ResMed Inc (RMD)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $235.21
    -4.10 (-1.71%)

    Market Cap: $33.66B

    Last updated: Nov 06, 2026 at 4:42 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(36/40)
    Avg Surprise
    +5.65%
    Streak
    13 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$2.99
    Range$2.93 - $3.06
    13 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$3.01-1.0%
    60d ago$3.04-1.7%
    30d ago$3.03-1.5%
    7d ago$3.02-1.2%
    Current$2.99
    Revenue Consensus
    $1.5B
    Range$1.4B - $1.5B
    16 analysts
    Period ending Mar 31, 2027
    EPS Consensus$3.08
    Range$3.02 - $3.17
    13 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$3.04+1.1%
    60d ago$3.14-2.0%
    30d ago$3.15-2.2%
    7d ago$3.14-2.2%
    Current$3.08
    Revenue Consensus
    $1.5B
    Range$1.4B - $1.5B
    16 analysts
    Last 12 of 40 reported quarters and 3 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Jun 27EST
    		-$3.38$3.08 - $3.50--20--
    Mar 27EST
    		-$3.08$3.02 - $3.17--13
    1
    0
    30d
    		-
    Dec 26EST
    		-$2.99$2.93 - $3.06--13
    0
    1
    30d
    		-
    Sep 26
    Reported Oct 29
    		$2.91$2.67$2.62 - $2.76+8.99%Beat13
    0
    1
    30d
    		+14.1%
    Jun 26
    Reported Aug 6
    		$2.95$2.90$2.78 - $2.98+1.72%Beat9
    0
    1
    30d
    		+15.7%
    Mar 26
    Reported Apr 30
    		$2.86$2.80$2.72 - $2.85+2.14%Beat13
    1
    2
    30d
    		+20.7%
    Dec 25
    Reported Jan 29
    		$2.81$2.72$2.63 - $2.87+3.31%Beat14
    1
    0
    30d
    		+15.6%
    Sep 25
    Reported Oct 30
    		$2.55$2.50$2.45 - $2.56+2.00%Beat12
    No revisions (30d)
    		+15.9%
    Jun 25
    Reported Jul 31
    		$2.55$2.48$2.35 - $2.60+2.82%Beat13
    7
    3
    30d
    		+22.6%
    Mar 25
    Reported Apr 23
    		$2.37$2.36$2.32 - $2.41+0.42%Beat12
    3
    6
    30d
    		+11.3%
    Dec 24
    Reported Jan 30
    		$2.43$2.31$2.26 - $2.38+5.19%Beat13
    0
    1
    30d
    		+29.3%
    Sep 24
    Reported Oct 24
    		$2.20$2.04$1.99 - $2.12+7.84%Beat8
    1
    0
    30d
    		+34.1%
    Jun 24
    Reported Aug 1
    		$2.08$2.07$1.95 - $2.18+0.48%Beat11
    No revisions (30d)
    		+30.0%
    Mar 24
    Reported Apr 25
    		$2.13$1.91$1.81 - $1.99+11.52%Beat10
    1
    0
    30d
    		+26.8%
    Dec 23
    Reported Jan 24
    		$1.88$1.78$1.68 - $1.90+5.62%Beat9
    1
    0
    30d
    		+13.3%

    Dividends

    Next ex-dividend: Nov 12, 2026

    Dividend Metrics

    Forward Yield1.12%
    Forward Annual Dividend$2.64
    Payout Ratio19.86%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+9.53%
    5Y CAGR+7.70%
    RMD dividend history and ex-dividend datesRun RMD in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio20.40EV/EBITDA15.12x
    Price/FCF20.90xFCF Yield4.78%
    Profitability
    Profit Margin27.80%Operating Margin34.80%
    ROE26.40%ROIC24.25%
    Financial Health
    Debt/Equity0.07xInterest CoverageN/A
    Current Ratio2.65xQuick Ratio1.88x
    Trading Statistics
    Beta0.76Avg Volume1.43M
    52-Week High$275.4252-Week Low$179.75

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$241.20
    SMA 20$241.78
    SMA 50$231.86
    SMA 200$223.72
    EMA 10$238.90
    EMA 20$238.53
    EMA 50$232.67
    EMA 200$227.64

    MACD

    Line: 1.73Signal: 3.60Hist: -1.87

    ADX

    ADX: 27.6+DI: 25.7-DI: 22.4

    Aroon & PSAR

    Aroon Up60.0
    Aroon DownN/A
    PSAR$248.45

    Bollinger Bands

    Upper Band$258.47
    Lower Band$225.08
    %B Position1381%(Upper)
    Band Width0.30

    RSI (14-Day)

    Neutral
    48.2

    Momentum Oscillators

    Stoch %K49.3
    Stoch %D40.3
    Williams %R-59.9
    ROC (10d)-7.0%
    Momentum-17.65
    CCI (20d)-67.2
    MFI (14d)52.2

    Volatility Measures

    ATR (14d)$8.09(3.4%)
    StdDev (20d)8.35
    Hist Vol45.8%(High)

    Volume Flow

    VWAP$234.61
    OBV-15.2M
    AD Line-193.2M
    CMF (20d)0.191

    Volume Metrics

    Avg Vol (20d)1.5M
    Vol Ratio1.1x
    VWMA (20d)$240.13

    Pivot Points

    R3$259.85
    R2$253.26
    R1$246.29
    Pivot Point$239.70
    S1$232.73
    S2$226.14
    S3$219.17

    Advanced Oscillators

    TSI7.36
    Ultimate Osc50.2
    KST68.26

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$1.41B$1.46B$1.43B$1.42B$1.34B$1.35B$1.29B$1.28B$1.22B$1.22B$1.20B$1.16B
    Cost of Revenue$544.25M$602.43M$540.43M$544.08M$517.92M$527.93M$525.33M$530.81M$507.29M$507.67M$504.20M$515.87M
    Gross Profit$870.57M$861.22M$890.98M$878.72M$817.66M$820.07M$766.41M$751.27M$717.22M$715.53M$692.78M$646.93M
    Operating Expenses$417.58M$412.51M$391.17M$387.06M$371.13M$365.53M$340.14M$334.03M$329.91M$334.31M$318.20M$371.84M
    R&D$102.86M$105.73M$94.27M$90.97M$89.48M$86.44M$83.94M$81.37M$79.52M$80.86M$77.07M$73.88M
    SG&A$314.72M$296.28M$285.65M$278.40M$281.65M$265.13M$245.30M$241.61M$238.98M$242.19M$229.92M$222.16M
    Operating Income$452.98M$448.71M$499.81M$491.66M$446.54M$454.54M$426.27M$417.24M$387.31M$381.22M$374.58M$275.09M
    Interest Income$23.08M$23.12M$14.01M$9.46M$11.21M$1.27M$335,000$1.08M$963,000$-5,052,000$-10,586,000$-13,066,000
    Interest Expense$4.81M$0$0$0$7.12M$0$8.57M$0$3.81M$23.49M$0$15.64M
    Income Before Tax$539.15M$474.16M$502.31M$496.15M$446.79M$458.05M$417.69M$418.32M$383.50M$357.73M$375.42M$259.45M
    Income Tax Expense$120.74M$90.73M$103.58M$103.56M$98.26M$78.35M$52.65M$73.70M$72.14M$65.50M$74.93M$50.65M
    Net Income$418.41M$383.43M$398.73M$392.59M$348.54M$379.70M$365.04M$344.62M$311.36M$292.24M$300.49M$208.80M
    EBITDA$572.72M$506.17M$557.34M$549.01M$500.37M$525.32M$468.48M$473.92M$437.90M$417.54M$440.65M$325.89M
    EBIT$520.89M$451.05M$488.31M$486.68M$442.70M$451.03M$416.56M$418.02M$384.19M$362.78M$386.01M$272.52M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RMD

    News

    Healthcare Stocks on ASX Today: Fisher & Paykel Healthcare Corporation, Pro Medicus and Resmed Inc Shares Move Across the Sector

    On November 6, 2026, Fisher & Paykel Healthcare Corporation Ltd (FPH) and Resmed Inc (RMD) saw slight gains on the ASX, rising 0.80% and 0.41% respectively...

    Kalkine•11/6/26•Somewhat-Bullish

    ResMed (ASX:RMD) Slides Despite a Solid Quarter: Why?

    ResMed's stock fell sharply despite reporting strong September-quarter revenue and earnings, led by sleep devices and masks. The market reaction is attributed to high expectations, slightly softer operating margins...

    Kalkine Media•11/6/26•Somewhat-Bearish

    AIA Group Ltd Sells 10,019 Shares of AMETEK, Inc. $AME

    AIA Group Ltd reduced its stake in AMETEK, Inc. (NYSE:AME) by 29.1%, selling 10,019 shares, though its remaining holdings are valued at over $6 million. Other institutional investors showed mixed activity...

    MarketBeat•11/5/26•Somewhat-Bullish

    After repaying 99% of its third-party debt, Genius Group seeks an Australian listing.

    Genius Group (NYSE American: GNS) announced its board has approved proceeding with a formal application for a dual listing on the Australian Securities Exchange (ASX) via CHESS Depositary Interests. This decision follows...

    Stock Titan•11/4/26•Somewhat-Bullish

    ResMed Inc. $RMD Shares Sold by Sumitomo Mitsui Trust Group Inc.

    Sumitomo Mitsui Trust Group Inc. reduced its stake in ResMed Inc. (NYSE:RMD) by 3.3% during the third quarter, selling 11,350 shares but still retaining a significant holding valued at $74.4 million. Despite the sale...

    MarketBeat•11/4/26•Somewhat-Bullish

    RMD Valuation and Fair Value

    P/E
    20.4x
    Forward P/E
    20.0x
    EV/EBITDA
    15.1x
    P/FCF
    20.9x
    PEG
    1.3x
    P/B
    5.7x
    See GNG's fair value

    RMD Profitability: Margins, ROIC and FCF

    Gross margin
    61.1%
    Operating margin
    34.8%
    Net margin
    27.8%
    ROIC
    24.3%
    ROE
    26.4%
    FCF margin
    28.1%
    FCF yield
    4.8%

    RMD Competitors

    CompanyTicker
    Zoetis IncZTS
    Genmab ASGMAB
    Mettler-Toledo International IncMTD
    DexCom IncDXCM
    Biogen IncBIIB
    Illumina IncILMN
    Centene CorpCNC
    Koninklijke Philips NV ADRPHG

    Sector: Healthcare

    RMD Analyst Ratings

    Consensus
    Hold
    Analysts
    20
    Strong Buy
    2
    Buy
    7
    Hold
    10
    Sell
    1
    Strong Sell
    0

    RMD Bull Case vs Bear Case

    Bull case

    • RMD earns a 24.3% return on invested capital.
    • RMD converts 28.1% of revenue into free cash flow.
    • RMD has a 27.8% net profit margin.

    RMD Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    3.3%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $2.99
    Estimate revisions (30 days, fiscal period ending Dec 31, 2026)
    0 up, 1 down

    RMD Dividend

    Forward yield
    1.1%
    Payout ratio
    19.9%
    3Y DPS growth
    9.5%
    5Y DPS growth
    7.7%
    Pay months
    Mar, Jun, Sep, Dec
    RMD dividend history

    RMD Earnings Date

    RMD reports Jan 27, 2027. The date is estimated.

    RMD Earnings Call

    The latest RMD earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    RMD ETF Holders

    GNG tracks 46 ETFs that hold RMD. The largest weights:

    1. iShares U.S. Medical Devices ETF (IHI), 4.77% of the fund
    2. State Street SPDR S&P Health Care Equipment ETF (XHE), 1.75% of the fund
    3. Invesco S&P 500 Equal Weight Health Care ETF (RSPH), 1.64% of the fund
    4. ERShares Private-Public Crossover ETF (XOVR), 1.47% of the fund
    5. SMOT, 0.74% of the fund
    Open the ETF Stock Exposure tool for RMD

    See insider activity

    Frequently Asked Questions About RMD

    When is RMD's next ex-dividend date?

    RMD's next ex-dividend date is Nov 12, 2026, for a declared dividend of $0.66 per share (record date Nov 12, 2026, payable Dec 17, 2026).

    When does RMD report earnings?

    ResMed Inc (RMD) is expected to report earnings on Jan 27, 2027.

    What is RMD's current dividend yield?

    ResMed Inc (RMD) has a forward dividend yield of 1.12%.

    Does RMD pay dividends?

    Yes, ResMed Inc pays dividends with a forward dividend yield of 1.12%.

    What is RMD's P/E ratio?

    ResMed Inc has a price-to-earnings (P/E) ratio of 20.40.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In